Clinical Pharmacology Corner: FDA Announces Primary Pediatric Hypertension Workshop

FDA Announces Primary Pediatric Hypertension Workshop on September 25, 2017

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institutes of Health (NIH) in collaboration with the U.S. Food and Drug Administration (FDA) and National Heart Lung and Blood Institute (NHLBI) NIH will hold a workshop titled “Primary Pediatric Hypertension Workshop: Epidemiology and Treatment Gaps.” The purpose of this one-day workshop is to discuss the current state of hypertension epidemiology, pathophysiology, diagnosis, and treatment in the pediatric population. The goal of the workshop is to identify research priorities for the improved diagnosis and treatment of primary hypertension in the pediatric population.

The workshop will bring together representatives and leading experts from NIH, FDA, academia, and industry to discuss the potential growing rates of undiagnosed hypertension in children related to the rising rates of obesity in this country. Workshop modules will address requirements for appropriate detection and treatment of primary pediatric hypertension, including an extensive knowledge of the epidemiology and current diagnostic criteria for primary pediatric hypertension (Module 1), the pathophysiology of primary pediatric hypertension (Module 2), and the current knowledge of and future directions in the treatment of primary pediatric hypertension (Module 3). 

The date, time, and location of the workshop are as follows:

Date: Monday, September 25, 2017
Time: 8:15 a.m. to 4:30 p.m.
Location: NICHD Offices at 6710B Rockledge Drive, 1st Floor Conference Rooms (1425/1427) in Bethesda, MD 20817

The draft agenda for the workshop is available here.

Registration can be accessed here. 

For further information regarding the workshop, visit here or contact:

Perdita Taylor-Zapata, M.D., Medical Officer
Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB)
Eunice Kennedy Shriver NICHD, National Institutes of Health (NIH)
taylorpe@mail.nih.gov

Gilbert J. Burckart, Pharm.D.
Associate Director for Pediatrics
Office of Clinical Pharmacology
10903 New Hampshire Ave.
Silver Spring, MD 20993
301-796-2065
gilbert.burckart@fda.hhs.gov